Page last updated: 2024-12-08

cotinine n-glucuronide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cotinine N-glucuronide: structure given in first source; a major urinary metabolite of nicotine [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID178540
MeSH IDM0204524

Synonyms (12)

Synonym
(2s,3s,4s,5r,6r)-3,4,5-trihydroxy-6-[3-[(2s)-1-methyl-5-oxopyrrolidin-2-yl]pyridin-1-ium-1-yl]oxane-2-carboxylate
unii-e3pe1559sw
pyridinium, 1-beta-d-glucopyranuronosyl-3-(1-methyl-5-oxo-2-pyrrolidinyl)-, inner salt, (s)-
cotinine n-glucuronide
139427-57-9
e3pe1559sw ,
cotinine n-beta-d-glucuronide
DTXSID60930470
pyridinium, 1-beta-d-glucopyranuronosyl-3-[(2s)-1-methyl-5-oxo-2-pyrrolidinyl]-, inner salt
(2s,3s,4s,5r,6r)-3,4,5-trihydroxy-6-(3-((s)-1-methyl-5-oxopyrrolidin-2-yl)pyridin-1-ium-1-yl)tetrahydro-2h-pyran-2-carboxylate
cotinine n-.beta.-d-glucuronide
pyridinium, 1-.beta.-d-glucopyranuronosyl-3-((2s)-1-methyl-5-oxo-2-pyrrolidinyl)-, inner salt

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"Epidemiologic studies show a dose-response relationship between cigarettes per day and health outcomes such as heart and lung disease, and health outcomes are related to some biomarkers of tobacco exposure."( Relationships between cigarette consumption and biomarkers of tobacco toxin exposure.
Carmella, SG; Han, S; Hatsukami, DK; Hecht, SS; Joseph, AM; Le, CT; Murphy, SE; Zhang, Y, 2005
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pathways (1)

PathwayProteinsCompounds
Nicotine Pathway, Pharmacokinetics129

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (28.57)18.2507
2000's6 (42.86)29.6817
2010's4 (28.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.60 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.49 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (13.33%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (86.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]